Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN,OTCQB:KHRNF), a cannabis company with core operations in Latin America announced today its financial results for the second quarter ended June 30, 2019. These filings are available for review on the Company’s SEDAR profile at www.sedar.com All financial information in this press release is reported in Canadian...